GE’s (NYSE:GE) Healthcare Equipment Revenue declined from around $11.5 billion in 2019 to about $9.8 billion in 2020. Trefis expects the number to decline further to around $9.5 billion in 2021 although it should recover to around $9.8 billion in 2022.
- Should You Buy General Electric Stock At $65?
- Forecast Of The Day: General Electric Aviation Revenues
- What’s Happening With General Electric Stock?
- This Industrial Company Is A Better Bet Over General Electric Stock
- Company Of The Day: General Electric
- How Will General Electric Stock Trend Following Q4 Earnings?
While sales were impacted due to the Covid-19 pandemic, we expect longer-term growth to be driven by the company’s market-leading products and higher demand from emerging economies.
While GE’s stock price has almost doubled over the last 12 months, driven by an improving growth outlook for its aviation and healthcare operations, we think it still remains undervalued. We value GE at about $117 per share, a premium of around 17% over the current market price.